Armed with an ever-growing understanding of cancer biology, Corellia AI was launched out of Champions Oncology, Inc. in 2023, leveraging Champions’ deep cancer dataset, rich suite of research platforms, and state-of-the-art experimental capabilities established over the past 15 years.
Corellia AI has built a unique research ecosystem and partnered with world-leading biopharma and technology companies to execute our vision of building transformative first-in-class therapeutics.
Company Details
- Employees
- 7
- Founded
- 2023
- Address
- Rockville, Md, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://corellia.ai/
- Keywords
- oncology, Drug Discovery, Drug Development.
- HQ
- Rockville, MD
Corellia Ai Questions
Corellia Ai's website is https://corellia.ai/
Corellia Ai's LinkedIn profile is https://www.linkedin.com/company/corellia-ai
Corellia Ai has
7 employees.
View email and phone details for 7
employees at Corellia Ai.
Corellia Ai's industry is
Biotechnology Research
Corellia Ai's top competitors are
Champions Oncology, Inc.,
Corellia,
Typewriter Therapeutics, Inc.,
Delphia Therapeutics,
Crown Bioscience,
Certis Oncology Solutions, Inc.,
Airna,
Dnanexus,
Ai Proteins,
Jsr Life Sciences.
Corellia Ai's categories are Biotechnology Research
Corellia Ai's founding year is 2023
